Azulvig could be huge! RedHawk would love a piece of this market
By some estimates, the global erectile dysfunction drug market is expected to reach $3.2 billion by 2022 (Grand View Research Inc., 2015). Sildenafil accounts for more than 40% of the total global market and is generally considered as the first line of treatment for erectile dysfunction (IMS data).
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.